These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. A new endoscopic staging system for hereditary hemorrhagic telangiectasia. Reh DD; Yin LX; Laaeq K; Merlo CA Int Forum Allergy Rhinol; 2014 Aug; 4(8):635-9. PubMed ID: 24782401 [TBL] [Abstract][Full Text] [Related]
12. Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: a double-blind, randomized, placebo-controlled trial. Riss D; Burian M; Wolf A; Kranebitter V; Kaider A; Arnoldner C Head Neck; 2015 Jun; 37(6):783-7. PubMed ID: 24595923 [TBL] [Abstract][Full Text] [Related]
13. ELLIPSE Study: a Phase 1 study evaluating the tolerance of bevacizumab nasal spray in the treatment of epistaxis in hereditary hemorrhagic telangiectasia. Dupuis-Girod S; Ambrun A; Decullier E; Samson G; Roux A; Fargeton AE; Rioufol C; Schwiertz V; Disant F; Chapuis F; Donazzolo Y; Paintaud G; Edery P; Faure F MAbs; 2014; 6(3):794-9. PubMed ID: 24481211 [TBL] [Abstract][Full Text] [Related]
14. Randomized, double-blind, placebo-controlled, crossover trial of oral doxycycline for epistaxis in hereditary hemorrhagic telangiectasia. Thompson KP; Sykes J; Chandakkar P; Marambaud P; Vozoris NT; Marchuk DA; Faughnan ME Orphanet J Rare Dis; 2022 Nov; 17(1):405. PubMed ID: 36344987 [TBL] [Abstract][Full Text] [Related]
16. TIMolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (TIM-HHT)-A Prospective, Randomized, Double-Blind, Controlled, Cross-Over Trial. Andorfer KEC; Zeman F; Koller M; Zeller J; Fischer R; Seebauer CT; Vielsmeier V; Bohr C; Kühnel TS Pharmaceutics; 2022 Oct; 14(11):. PubMed ID: 36365152 [TBL] [Abstract][Full Text] [Related]
17. Intranasal topical estrogen in the management of epistaxis in hereditary hemorrhagic telangiectasia. Minami K; Haji T Acta Otolaryngol; 2016; 136(5):528-31. PubMed ID: 26808464 [TBL] [Abstract][Full Text] [Related]
18. Treatments of Epistaxis in Hereditary Hemorrhagic Telangiectasia: Systematic Review and Network Meta-Analysis. Chitsuthipakorn W; Hoang MP; Kanjanawasee D; Seresirikachorn K; Snidvongs K Curr Allergy Asthma Rep; 2023 Dec; 23(12):689-701. PubMed ID: 37995018 [TBL] [Abstract][Full Text] [Related]
19. Topical application of timolol decreases the severity and frequency of epistaxis in patients who have previously undergone nasal dermoplasty for hereditary hemorrhagic telangiectasia. Ichimura K; Kikuchi H; Imayoshi S; Dias MS Auris Nasus Larynx; 2016 Aug; 43(4):429-32. PubMed ID: 26739947 [TBL] [Abstract][Full Text] [Related]
20. Septectomy and septal dermoplasty for the treatment of severe transfusion-dependent epistaxis in patients with hereditary hemorrhagic telangiectasia and septal perforation. Lesnik GT; Ross DA; Henderson KJ; Joe JK; Leder SB; White RI Am J Rhinol; 2007; 21(3):312-5. PubMed ID: 17621815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]